Dr Stephen Hahn appointed as new FDA commissioner

The US Food and Drug Administration (FDA) has been appointed its new commissioner, reports Reuters. Dr Stephen Hahn was confirmed as the new head of the regulatory body on Thursday.

According to the outlet, Hahn is a radiation oncologist who was nominated for his new role by President Donald Trump.

Hahn is currently the chief medical executive of the University of Texas in Houston.

The US Senate decided for Hahn as commissioner in a 72 to 18 vote.  

Scott Gottlieb, the previous FDA commissioner, stepped down in April, with Ned Sharpless serving as acting FDA commissioner in the interim.

Editor's Note:

En-CPhI.CN is a vertical B2B online trade platform serving the pharmaceutical industry,

for any copyright disputes involved in the reproduced articles,

please email: Julia.Zhang@ubmsinoexpo.com to motify or remove the content.